Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways

  • Published : 2013.04.30


Colorectal cancer (CRC) is one of the most common cancers in many parts of the world. Its development is a multi-step process involving three distinct stages, initiation that alters the molecular message of a normal cell, followed by promotion and progression that ultimately generates a phenotypically altered transformed malignant cell. Reports have suggested an association of the phosphoinositide-3-kinase (PI3K)/Akt pathway with colon tumorigenesis. Activation of Akt signaling and impaired expression of phosphatase and tensin homolog (PTEN) (a negative regulator of Akt) has been reported in 60-70% of human colon cancers and inhibitors of PI3K/Akt signaling have been suggested as potential therapeutic agents. Around 80% of human colon tumors possess mutations in the APC gene and half of the remainder feature ${\beta}$-catenin gene mutations which affect downstream signaling of the PI3K/Akt pathway. In recent years, there has been a great focus in targeting these signaling pathways, with natural and synthetic drugs reducing the tumor burden in different experiment models. In this review we survey the role of PI3K/Akt/mTOR and Wnt signaling in CRC.


  1. Allameh A, Dadkhah A, Rahbarizadeh F, et al (2012). Effect of dietary caraway essential oils on expression of ${\beta}$-catenin during 1,2-dimethylhydrazine-induced colonic carcinogenesis. J Nat Med, [Epub ahead of print].
  2. Ashokkumar, P, Sudhandiran G (2008). Protective role of Luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharmacother, 62, 590-7.
  3. Ashokkumar P, Sudhandiran G (2011). Luteolin inhibits cell proliferation during azoxymethane-induced experimental colon carcinogenesis via Wnt/${\beta}$-catenin pathway. Invest New Drugs, 29, 273-84.
  4. Aviello G, Romano B, Borrelli F, et al (2012). Chemopreventive effect of the non-psychotrophic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl), 90, 925-34.
  5. Behrens J (2000). Control ${\beta}$-catenin signaling in tumor development. Ann NY Acad Sci, 910, 21-33.
  6. Boland GM, Perkins G, Hall DJ, Tuan RS (2004). Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem, 93, 1210-30.
  7. Brudvik KW, Paulsen JE, Aandahl EM, et al (2011). Protein kinase A antagonist inhibits ${\beta}$-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in APC(Min/+) mice. Mol Cancer, 10, 149.
  8. Chang YJ, Huang YP, Li ZL, Chen CH (2012). GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells. PLoS One, 7, 35123.
  9. Cho HH, Kim YJ, Kim SJ, et al (2006). Endogenous Wnt signaling promotes proliferation and suppresses osteogenic differentiation in human adipose derived stromal cells. Tissue Eng, 12, 111-21.
  10. Chung CS, Jiang Y, Cheng D, Birt DF (2007). Impact of adenomatous polyposis coli (APC) tumor suppressor gene in human colon cancer cell lines on cell cycle arrest by apigenin. Mol Carcinogenesis, 46, 773-82.
  11. Colakoglu T, Yildirim S, Kayaselcuk F, et al (2008). Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence. Am J Surg, 195, 71925.
  12. Dashwood RH, Suzui M, Nakagama H, Sugimura T, Nagao M (1998). High frequency of ${\beta}$-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res, 58, 1127-9.
  13. Din FV, Valanciute A, Houde VP, et al (2012). Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterol, 142, 1504-15.
  14. Engelman JA (2009). Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer, 9, 550-62.
  15. Funayama N, Fagotto F, McCrea P, Gumbiner BM (1995). Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling. J Cell Biol, 128, 959-68.
  16. Giovannucci E, Stampfer MJ, Colditz G, et al (1992). Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst, 84, 91-8.
  17. Granda TG, Cebrian D, Martinez S, et al (2012). Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases. Invest New Drugs, 31, 66-76.
  18. Greenspan EJ, Madigan JP, Boardman LA, Rosenberg DW (2011). Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila), 4, 161-71.
  19. He TC, Sparks AB, Rago C, et al (1998). Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-12.
  20. Heasman J, Crawford A, Goldstone K et al (1994). Overexpression of cadherins and under expression of beta-catenin inhibit dorsal mesoderm induction in early xenopus embryos. Cell, 79, 791-803.
  21. Herbst A, Kolligs FT (2007). Wnt signaling as a therapeutic target for cancer. Methods Mol Biol; 361, 63-91.
  22. Hirsch E, Katanaev VL, Garlanda C, et al (2000). Central role for G protein-coupled phosphoinositide 3-kinase ${\gamma}$ in inflammation. Science, 287, 1049-53.
  23. Itzkowitz SH, Yio X (2004). Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol , 287, 7-17.
  24. Jastrzebski K, Hannan KM, Tchoubrieva EB, Hannan RD, Pearson RB (2007). Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors, 25, 209-26.
  25. Jung F, Haendeler J, Goebel C, Zeiher AM, Dimmeler S (2000). Growth factor induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res, 48, 148-57.
  26. Kang HW, Kim JM, Cha MY, et al (2012). Deguelin, an Akt Inhibitor, down-regulates NF-${\kappa}$B signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice. Dig Dis Sci, 57, 2873-82.
  27. Kang YJ, Park HJ, Chung HJ, et al (2012). Wnt/${\beta}$-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Mol Pharmacol, 82, 168-77.
  28. Kansal S, Negi AK, Bhatnagar A, Agnihotri N (2012). Ras signaling pathway in the chemopreventive action of different ratios of fish oil and corn oil in experimentally induced colon carcinogenesis. Nutr Cancer, 64, 559-68.
  29. Kim DJ, Reddy K, Kim MO, et al (92011). (3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo. Cancer Prev Res (Phila), 4, 1842-51.
  30. Koehl GE, Spitzner M, Ousingsawat J, et al (2010). Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice. Oncogene, 29, 1553-60.
  31. Korinek V, Barker N, Morin PJ, et al (1997). Constitutive transcriptional activation by a ${\beta}$-catenin-Tcf complex in APC-/-colon carcinoma. Science, 275, 1784-7.
  32. Kumar A, Panduranagan AK, Lu F, et al (2012). Chemopreventive sphigadienes downregulate Wnt signaling via PP2A/Akt/ GSK3${\beta}$ pathway in colon cancer. Carcinogenesis, 53, 1920-31.
  33. Lai CS, Wu JC, Yu SF, et al (2011). Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethaneinduced colon carcinogenesis. Mol Nutr Food Re, 55, 1819-28.
  34. Laurent MN, Blitz IL, Hashimoto C, et al (1997). The Xenopus homeobox gene twin mediates Wnt induction of goosecoid in establishment of spemann's organizer. Development, 124, 4905-16.
  35. Lee HC, Kim M, Wands JR (2006). Wnt/Frizzled signaling in hepatocellular carcinoma. Front Biosci, 11, 1901-15.
  36. Lee YC, Lin HH, Hsu CH, et al (2010). Inhibitory effects of andrographolide on migration and invasion in human nonsmall cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol, 632, 23-32.
  37. Lin MC, Wang FY, Kuo YH, Tang FY (2011). Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells. J Agric Food Chem, 59, 11304-18.
  38. Liu J, Shen M, Yue Z, et al (2012). Triptolide inhibits colonrectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomed, 19, 756-62.
  39. Loewith R, Jacinto E, Wullschleger S, et al (2002). Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell, 10, 457-68.
  40. Okkenhaug K, Bilancio A, Farjot G, et al (2002). Impaired Band T-cell antigen receptor signaling in p110${\delta}$ PI 3-kinase mutant mice. Science, 297, 1031-4.
  41. Palozza P, Torelli C, Boninsegna A, et al (2009). Growthinhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett, 283, 108-17
  42. Pandurangan AK, Periasamy S, Anandasadagopan SK, Ganapasam S, Chennam SS (2012a). Green tea polyphenol protection against 4-Nitroquinoline1-oxide-induced bone marrow lipid peroxidation and genotoxicity in wistar rats. Asian Pac J Cancer Prev, 13, 4107-12.
  43. Pandurangan AK, Dharmalingam P, Anandasadagopan SK, Ganapasam S (2012b). Effect of Luteolin on the levels of Glycoproteins during Azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev, 13, 1569-73.
  44. Pandurangan AK, Ganapasam S (2013a). Luteolin modulates cellular thiols on azoxymethane-induced colon carcinogenesis. Asian J Exp Biol Sci, 4, 245-50.
  45. Pandurangan AK, Ganapasam S (2013b). Luteolin induces apoptosis in azoxymethane-induced colon carcinogenesis through the involvement of Bcl-2, Bax and Caspase-3. J Chem Pharm Res, 5, 143-8.
  46. Park, CH, Chang JY, Hahm ER, Park S, et al (2005). Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun, 328, 227-34.
  47. Pause A, Belsham GJ, Gingras AC, et al (1994). Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature, 371, 762-7.
  48. Polakis P (2000). Wnt signaling and cancer. Genes Dev, 14, 1837-51.
  49. Ramos S, Rodriguez-Ramiro I, Martin MA, et al (2011). Dietary flavanols exert different effects on antioxidant defenses and apoptosis/proliferation in Caco-2 and SW480 colon cancer cells. Toxicol In Vitro, 25, 1771-81.
  50. Reddy BS (1986). Diet and colon cancer in: B.S. Reddy, L.A. Cohen (Eds.), in Evidence from Human and Animal Model Studies, CRC Press, Boca Raton, FL, pp. 47-65.
  51. Rychahou PG, Murillo CA, Evers BM (2005). Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis inducing ligand (TRAIL). Surgery, 138, 391-7.
  52. Saini MK, Sanyal SN (2012). PTEN regulates apoptotic cell death through PI3-K/Akt/GSK3${\beta}$ signaling pathway in DMH induced early colon carcinogenesis in rat. Exp Mol Pathol, 93, 135-46.
  53. Slattery SL, Benson J, Curtin K, et al (2000). Carotenoids and colon cancer. Am J Clin Nutr, 71, 575-82.
  54. Sonenberg N, Gingras AC (1998). The mRNA 5' cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol, 10, 268-75.
  55. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998). Mutational analysis of the APC/${\beta}$-catenin/Tcf pathway in colorectal cancer. Cancer Res, 58, 1130-4.
  56. Suzui M, Ushijima T, Dashwood RH, et al (1999). Frequent mutations of the rat ${\beta}$-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinogenesis, 24, 232-7.<232::AID-MC10>3.0.CO;2-M
  57. Symolon H, Bushnev A, Peng Q, et al (2011). Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer. Mol Cancer Ther, 10, 648-57.
  58. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K (1998). ${\beta}$-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res, 58, 42-6.
  59. Tang FY, Pai MH, Wang XD (2011). Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. J Agric Food Chem, 59, 9011-21.
  60. Tenesa A, Dunlop MG (2009). New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet, 10, 353-8.
  61. Terzic J, Grivennikov S, Karin E, Karin M (2010). Inflammation and colon cancer. Gastroenterol, 138, 2101-14.
  62. Tetsu O, McCormick F (1999). ${\beta}$-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-6.
  63. Um SH, D'Alessio D, Thomas G (2006). Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab, 3, 393-402.
  64. Umesalma S, Sudhandiran G (2011). Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur J Pharmacol, 660, 249-58.
  65. Vaish V, Sanyal SN (2012). Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: Exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/${\beta}$-catenin signaling. Biomed Pharmacother, 66, 354-67.
  66. Wang JY, Chang CC, Chiang CC, et al (2012). Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways. J Cell Biochem, 113, 1733-43.
  67. Wu K, Yang Q, Mu Y, et al (2012). Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/${\beta}$-catenin signaling. Int J Oncol, 41, 292-8.
  68. Wullschleger S, Loewith R, Hall MN (2006). mTOR signaling in growth and metabolism. Cell, 124, 471-84.
  69. Zhang Y and Chen H (2011). Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Exp Biol Med, 236, 714-22.

Cited by

  1. Dietary Non-nutritive Factors in Targeting of Regulatory Molecules in Colorectal Cancer: An Update vol.14, pp.10, 2013,
  2. Endometriosis, Leiomyoma and Adenomyosis: the Risk of Gynecologic Malignancy vol.14, pp.10, 2013,
  3. Chemopreventive Effect of Amorphophallus campanulatus (Roxb.) blume tuber against aberrant crypt foci and cell proliferation in 1, 2-dimethylhydrazine induced colon carcinogenesis vol.14, pp.9, 2013,
  4. Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer vol.110, pp.8, 2014,
  5. Expression of the E-cadherin/β-catenin/tcf-4 Pathway in Gastric Diseases with Relation to Helicobacter pylori Infection: Clinical and Pathological Implications vol.15, pp.1, 2014,
  6. DEPTOR Expression Negatively Correlates with mTORC1 Activity and Tumor Progression in Colorectal Cancer vol.15, pp.11, 2014,
  7. Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review vol.15, pp.14, 2014,
  8. Prognostic Significance of Beta-Catenin Expression in Patients with Esophageal Carcinoma: a Meta-analysis vol.15, pp.15, 2014,
  9. The mTOR Signalling Pathway in Cancer and the Potential mTOR Inhibitory Activities of Natural Phytochemicals vol.15, pp.16, 2014,
  10. GRP78 Secreted by Colon Cancer Cells Facilitates Cell Proliferation via PI3K/Akt Signaling vol.15, pp.17, 2014,
  11. Signal Transducer and Activator of Transcription 3 - A Promising Target in Colitis-Associated Cancer vol.15, pp.2, 2014,
  12. Spinal Cord Regeneration vol.23, pp.4-5, 2014,
  13. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling vol.24, pp.1, 2014,
  14. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis vol.33, pp.11, 2014,
  15. Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27 vol.35, pp.9, 2014,
  16. Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1 vol.9, pp.1, 2014,
  17. Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cells vol.10, pp.4, 2015,
  18. Dexamethasone Disrupts Cytoskeleton Organization and Migration of T47D Human Breast Cancer Cells by Modulating the AKT/mTOR/RhoA Pathway vol.15, pp.23, 2015,
  19. Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/β-catenin Signaling Pathways in a Cholangiocarcinogenesis Model vol.15, pp.23, 2015,
  20. Association of the PTEN IVS4 (rs3830675) Gene Polymorphism with Reduced Risk of Cancer: Evidence from a Meta-analysis vol.16, pp.3, 2015,
  21. MicroRNA-128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1 vol.34, pp.5, 2015,
  22. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway vol.35, pp.5, 2015,
  23. Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR signaling-dependent MMP7 modulation vol.36, pp.2, 2015,
  24. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway vol.48, pp.1, 2015,
  25. ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis vol.5, pp.1, 2015,
  26. Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice vol.60, pp.2, 2015,
  27. Zinc finger protein X-linked is overexpressed in colorectal cancer and is associated with poor prognosis pp.1792-1082, 2015,
  28. PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma vol.14, pp.1, 2016,
  29. Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway vol.36, pp.1, 2016,
  30. Autophagy inhibition sensitizes WYE-354-induced anti-colon cancer activity in vitro and in vivo vol.37, pp.9, 2016,
  31. miR-92b regulates glioma cells proliferation, migration, invasion, and apoptosis via PTEN/Akt signaling pathway vol.72, pp.2, 2016,
  32. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms vol.12, pp.1, 2017,
  33. Effects of Thymoquinone on IL-6 Gene Expression and Some Cellular Signaling Pathways in Prostate Cancer PC3 Cells vol.12, pp.3, 2017,
  34. Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer vol.233, pp.2, 2017,
  35. Curcumin and Salsalate Suppresses Colonic Inflammation and Procarcinogenic Signaling in High-Fat-Fed, Azoxymethane-Treated Mice vol.65, pp.33, 2017,
  36. Extracellular 5′-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway pp.00207136, 2017,
  37. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway pp.07302312, 2017,
  38. The Presence of Anti-GRP78 Antibodies in the Serum of Patients with Colorectal Carcinoma: A Potential Biomarker for Early Cancer Detection vol.29, pp.4, 2014,
  39. Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review) vol.48, pp.2, 2015,
  40. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention vol.309, pp.2, 2015,
  41. Incidence of Malignancy and the Risk of Lymphoma in Japanese Patients with Rheumatoid Arthritis Compared to the General Population vol.42, pp.4, 2015,
  42. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation vol.31, pp.3, 2016,
  43. PERM Hypothesis: The Fundamental Machinery Able to Elucidate the Role of Xenobiotics and Hormesis in Cell Survival and Homeostasis vol.18, pp.1, 2017,
  44. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer vol.17, pp.1, 2018,
  45. New Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple-Negative Breast Cancer vol.2018, pp.1942-0994, 2018,
  46. Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway vol.09, pp.03, 2018,
  47. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis vol.9, pp.6, 2018,
  48. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway vol.29, pp.6, 2018,
  49. as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma vol.119, pp.7, 2018,
  50. Synthesis, characterization, and bioactivity of new bisamidrazone derivatives as possible anticancer agents vol.27, pp.5, 2018,
  51. The Combination of Curcumin and Salsalate is Superior to Either Agent Alone in Suppressing Pro‐Cancerous Molecular Pathways and Colorectal Tumorigenesis in Obese Mice pp.1613-4133, 2019,